Integrin blocker polypeptide as well as preparation method and application thereof
An integrin blocker and technology for use, applied in the direction of peptide preparation methods, chemical instruments and methods, peptides, etc., can solve the problems of short half-life, easy degradation in the body, etc., achieve small side effects, reduce the number of amino acids, and reduce synthesis cost effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0056] Preparation and Test of Integrin Blocker Polypeptide Synthetic Peptide Ⅰ-X
[0057] The peptide solid-phase synthesis method is adopted, which uses wang resin (Wang resin) as the starting material, and then uses the protected amino acid Fmoc-arginine-OH to sequentially connect one peptide to eight, nine, ten to seventeen peptides, and the peptide connection work is completed After that, it is fully washed, and then the peptide is cut and post-treated to obtain the crude peptide. Purify the crude product by first dissolving it, then using preparative high-performance liquid phase for two purifications, and finally concentrating and freeze-drying to obtain the pure product. Specific steps are as follows:
[0058] 1. Synthesis:
[0059] Weigh 13g of Wang resin, pour it into a 1L reaction column with glass sand core, and add 130ml of CH2Cl2 to fully expand the resin.
[0060] Uncapping: Add 25mL of hexahydropyridine / DMF decapping solution, seal it and place it in a shake...
Embodiment 2
[0092] Protective effect of integrin blocker polypeptide on in vivo immune protection of adjuvanted rat arthritis animal model
[0093] An animal model of adjuvant arthritis in rats was constructed to study the therapeutic effect of integrin blocker polypeptide on adjuvant arthritis (AA) rats. Rats were used as the test animals. 238 clean-grade wistar rats, male, with a body weight of 150g-180g, were randomly divided into 34 groups, which were blank control group, model control group, and three dosage groups of polypeptide Ⅰ-X low, middle and high ( 3, 6, 9mg / kg) and the positive drug control group (methotrexate 1mg / kg), plus a HM-3 treatment dose group for comparison. Except for the blank group, rat AA models were established in each experimental group on the 0th day by injecting complete Freund's adjuvant containing inactivated Mycobacterium tuberculosis (H37RA, 10mg / ml) in the left hindquarters of the rats 0.08ml caused rat adjuvant arthritis model. Secondary inflammation...
Embodiment 3
[0112] Effects of Integrin Blocker Peptide on Corneal Neovascularization in Mice
[0113] 1) Preparation of corneal neovascularization model induced by alkali burn in BALB / c mice:
[0114] Fifty-five healthy BALB / c mice, male, weighing 20-25 g, were examined under a slit-lamp microscope for the anterior segments and appendages of both eyes to exclude eye lesions. 0.3% ofloxacin eye drops were instilled 1 day before the preparation of the alkali burn model, twice a day. After mice were anesthetized by intraperitoneal injection of 1.8% Avertin, a single-layer filter paper sheet with a diameter of 2 mm was clamped with tweezers, immersed in 1mol / L sodium hydroxide solution to make it saturated, excess liquid was removed, and the filter paper sheet was placed in BALB / c mouse corneal central 40S, discard the filter paper, immediately rinse the burn area and conjunctival sac with 15mL of PBS for 1min. Wipe off excess water with a cotton swab, and rotate the corneal spatula paralle...
PUM
Property | Measurement | Unit |
---|---|---|
Diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com